Antibiotic growth promoters

Population-Level Uncoupling of Antimicrobial Usage and Resistance in Community-Onset Escherichia coli Bloodstream Infections.

Pathogens (Basel, Switzerland)·2026

Tourism and the Global Vectoring of Antimicrobial-Resistant Disease: What Countries Are Most Impacted?

Antibiotics (Basel, Switzerland)·2025

Investigation of mobile genetic elements and their association with antibiotic resistance genes in clinical pathogens worldwide.

PloS one·2025

Protocol to establish standards for the elements of infection prevention and control programs and practice and competency standards for infection control professionals in Australian hospitals.

PloS one·2025

Gender differences in global antimicrobial resistance.

NPJ biofilms and microbiomes·2025

The Persistence of Antibiotic Resistance in Observational Studies: Is It Really Due to Differences in Sub-Populations Rather than Antibiotic Use?

Antibiotics (Basel, Switzerland)·2025

Characterization of the intrinsic AmpC β-lactamase of Escherichia marmotae and its impact on decreased susceptibility to cefiderocol and resistance to broad-spectrum cephalosporins.

The Journal of antimicrobial chemotherapy·2026

Epidemiology of KPC-producing Enterobacterales isolated from 2019 to 2023 in France.

The Journal of antimicrobial chemotherapy·2026

Determinants of levofloxacin prophylaxis failure in high-risk haematology patients: a prospective study integrating resistant colonization and pharmacokinetic/pharmacodynamic target attainment.

The Journal of antimicrobial chemotherapy·2026

Inter- and intraindividual variability of long-acting injectable cabotegravir/rilpivirine trough concentrations after 1 year of continuous use.

The Journal of antimicrobial chemotherapy·2026

Differential salivary disposition of linezolid and its two major metabolites (PNU-142300 and PNU-142586) after a single dose in healthy adults.

The Journal of antimicrobial chemotherapy·2026

Synergy between orally bioavailable antibiotics and dalbavancin against MRSA.

The Journal of antimicrobial chemotherapy·2026

Deep Vein Thrombosis Secondary to Brucellosis: An Uncommon Infectious Cause of Venous Thrombosis.

Case reports in infectious diseases·2026

Impact of microbiological testing protocols on discard rates in donor human milk with a focus on Bacillus cereus.

Frontiers in microbiology·2026

Dielectrophoretic Enrichment Coupled with Impedance Spectroscopy for Real-Time Bacterial Detection and Antibiotic Susceptibility Testing Using an Interdigitated Wave Electrode Array.

Sensors (Basel, Switzerland)·2026

Detection and Isolation of Psychrotrophic Acinetobacter spp. in Raw Milk from Ecuador: A Hidden Microbial Risk for Dairy Products.

Foods (Basel, Switzerland)·2026

Outer membrane as a drug target for the treatment of GNB infections.

Drug discovery today·2026

Beyond the growth curve: CBASS stops phages without killing.

Cell host & microbe·2026

Related Experiment Videos

Antibiotic growth promoters

Related Concept Videos

Population-Level Uncoupling of Antimicrobial Usage and Resistance in Community-Onset Escherichia coli Bloodstream Infections.

Tourism and the Global Vectoring of Antimicrobial-Resistant Disease: What Countries Are Most Impacted?

Investigation of mobile genetic elements and their association with antibiotic resistance genes in clinical pathogens worldwide.

Protocol to establish standards for the elements of infection prevention and control programs and practice and competency standards for infection control professionals in Australian hospitals.

Gender differences in global antimicrobial resistance.

The Persistence of Antibiotic Resistance in Observational Studies: Is It Really Due to Differences in Sub-Populations Rather than Antibiotic Use?

Characterization of the intrinsic AmpC β-lactamase of Escherichia marmotae and its impact on decreased susceptibility to cefiderocol and resistance to broad-spectrum cephalosporins.

Epidemiology of KPC-producing Enterobacterales isolated from 2019 to 2023 in France.

Determinants of levofloxacin prophylaxis failure in high-risk haematology patients: a prospective study integrating resistant colonization and pharmacokinetic/pharmacodynamic target attainment.

Inter- and intraindividual variability of long-acting injectable cabotegravir/rilpivirine trough concentrations after 1 year of continuous use.

Differential salivary disposition of linezolid and its two major metabolites (PNU-142300 and PNU-142586) after a single dose in healthy adults.

Synergy between orally bioavailable antibiotics and dalbavancin against MRSA.

Deep Vein Thrombosis Secondary to Brucellosis: An Uncommon Infectious Cause of Venous Thrombosis.

Impact of microbiological testing protocols on discard rates in donor human milk with a focus on Bacillus cereus.

Dielectrophoretic Enrichment Coupled with Impedance Spectroscopy for Real-Time Bacterial Detection and Antibiotic Susceptibility Testing Using an Interdigitated Wave Electrode Array.

Detection and Isolation of Psychrotrophic Acinetobacter spp. in Raw Milk from Ecuador: A Hidden Microbial Risk for Dairy Products.

Outer membrane as a drug target for the treatment of GNB infections.

Beyond the growth curve: CBASS stops phages without killing.

Related Experiment Videos

Antibiotic growth promoters

Related Concept Videos

Related Articles